Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0950
0.00 (0.00%)
Sep 10, 2026, 2:32 PM EST
Ventripoint Diagnostics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.15 | 0.18 | 0.1 | 0.05 | 0.07 | - | |
Revenue Growth | 8.79% | 89.06% | 93.51% | -27.85% | 89.26% | - |
Cost of Revenue | - | - | - | 0.01 | 0.01 | 0.01 |
Gross Profit | 0.15 | 0.18 | 0.1 | 0.04 | 0.06 | -0.01 |
Selling, General & Admin | 2.17 | 3.21 | 3.93 | 3.89 | 3.92 | 3.25 |
Research & Development | 0.38 | 0.37 | 0.97 | 1.08 | 1.05 | 0.46 |
Operating Expenses | 2.55 | 3.58 | 4.9 | 4.97 | 4.97 | 3.71 |
Operating Income | -2.4 | -3.4 | -4.8 | -4.93 | -4.91 | -3.72 |
Interest Expense | -0.55 | -0.53 | -0.18 | -0.06 | -0.03 | -0.01 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.08 | 0.03 | - |
Currency Exchange Gain (Loss) | -0.03 | -0.02 | -0.03 | -0.02 | -0.06 | -0 |
Other Non Operating Income (Expenses) | -0.02 | -0 | -0.01 | 0.06 | 0.1 | -0.07 |
EBT Excluding Unusual Items | -2.99 | -3.94 | -5.01 | -4.87 | -4.87 | -3.8 |
Other Unusual Items | 0.62 | 0.69 | 0.01 | - | - | -0.08 |
Pretax Income | -2.37 | -3.25 | -5 | -4.87 | -4.87 | -3.88 |
Income Tax Expense | -0.05 | -0.05 | -0.08 | - | - | - |
Net Income | -2.32 | -3.2 | -4.92 | -4.87 | -4.87 | -3.88 |
Net Income to Common | -2.32 | -3.2 | -4.92 | -4.87 | -4.87 | -3.88 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 178 | 165 | 158 | 157 | 156 | 136 |
Shares Outstanding (Diluted) | 178 | 165 | 158 | 157 | 156 | 136 |
Shares Change | 11.19% | 4.51% | 0.93% | 0.53% | 14.62% | 82.64% |
EPS (Basic) | -0.01 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
EPS (Diluted) | -0.01 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.92 | -1.55 | -3.39 | -3.8 | -4.14 | -3.15 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 |
Gross Margin | 100.00% | 100.00% | 100.00% | 86.28% | 84.80% | - |
Operating Margin | -1624.50% | -1889.37% | -5045.41% | -10024.80% | -7203.96% | - |
Profit Margin | -1568.51% | -1778.62% | -5169.14% | -9905.73% | -7148.33% | - |
Free Cash Flow Margin | -1301.93% | -864.19% | -3557.98% | -7734.16% | -6068.54% | - |
EBITDA | - | -3.4 | -4.8 | -4.93 | -4.9 | -3.7 |
D&A For EBITDA | - | 0 | 0 | 0.01 | 0.01 | 0.01 |
EBIT | -2.4 | -3.4 | -4.8 | -4.93 | -4.91 | -3.72 |